|
2010 Announcements 26 Aug 2010
Appendix 4D June 2010
26 Aug 2010
Interim Report 2010
25 Aug 2010
Appendix 3B (note) Aug 2010
20 Aug 2010
Appendix 3B (shares) Aug 2010
20 Aug 2010
Appendix 3B (options) Aug 2010
20 Aug 2010
Cleansing Statement
28 Jul 2010
Appendix 4C June 2010
23 Jul 2010
Appendix 3B (note) July 2010
21 Jul 2010
Appendix 3B (shares) July 2010
21 Jul 2010
Appendix 3B (options) July 2010
21 Jul 2010
Cleansing statement July 2010
21 Jul 2010
SpringTree becomes substantial shareholder
24 Jun 2010
Appendix 3B (note) June 2010
21 Jun 2010
Appendix 3B (shares) Jun 2010
21 Jun 2010
Appendix 3B (options) Jun 2010
21 Jun 2010
Cleansing statement Jun 2010
27 May 2010
Appendix 3B (note) May 2010
25 May 2010
CEO Presentation to AGM
25 May 2010
Results of AGM
21 May 2010
Appendix 3B (shares) May 2010
21 May 2010
Appendix 3B (options) May 2010
21 May 2010
Cleansing statement May 2010
6 May 2010
Neuren Starts Phase II Trial of NNZ-2566
30 Apr 2010
Appendix 4C Mar 2010
27 Apr 2010
Notice of AGM 2010
23 Apr 2010
Appendix 3B (note) Apr 2010
21 Apr 2010
Appendix 3B (shares) Apr 2010
21 Apr 2010
Appendix 3B (options) Apr 2010
21 Apr 2010
Cleansing statement Apr 2010
6 Apr 2010
Lapse of Unquoted Options Mar 2010
30 Mar 2010
Annual Report 2009
25 Mar 2010
Appendix 3B (ESOP options) Mar 2010
24 Mar 2010
Appendix 3B (note) Mar 2010
22 Mar 2010
Appendix 3B (options) Mar 2010
22 Mar 2010
Cleansing statement Mar 2010
22 Mar 2010
Appendix 3B (shares) Mar 2010
19 Mar 2010
Grant funding for TFF oncology program
3 Mar 2010
Trial of Motiva to be Initiated
26 Feb 2010
Preliminary Final Report 2009
22 Feb 2010
Appendix 3B (note) Feb 2010
18 Feb 2010
Cleansing statement Feb 2010
18 Feb 2010
Appendix 3B (options) Feb 2010
18 Feb 2010
Appendix 3B (shares) Feb 2010
11 Feb 2010
Cato strategic partnership and US CMO
29 Jan 2010
Appendix 4C Dec 2009
20 Jan 2010
Appendix 3B (note)
|
